Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma

As the most common subtype of non-Hodgkin's lymphoma, diffuse large B-cell lymphoma (DLBCL) is characterized by a huge degree of clinical and prognostic heterogeneity. Currently, there is an urgent need for highly specific and sensitive biomarkers to predict the therapeutic response of DLBCL an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xiao-jie, Song, Xin-yu, Wu, Jia-lin, Liu, Dan, Lin, Bing-yu, Zhou, Hong-sheng, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898353/
https://www.ncbi.nlm.nih.gov/pubmed/35280688
http://dx.doi.org/10.7150/ijbs.67892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898353/
https://www.ncbi.nlm.nih.gov/pubmed/35280688
http://dx.doi.org/10.7150/ijbs.67892

Ejemplares similares